*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ribociclib is a selective <strong>CDK4/6 inhibitor</strong> developed for oncology. Synthesized via advanced organic coupling, its molecular formula is <strong>C28H31N7O3</strong> (CAS: 933573-25-0).</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> API production for HR+/HER2- breast cancer therapies.</li>
<li><strong>Pharmaceutical Research:</strong> Clinical trial supply for combination regimens with endocrine therapy.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store below 25°C in dry conditions. Monitor QTc interval clinically; avoid use in patients with severe hepatic impairment or known hypersensitivity.</p>